Abercrombie & Fitch Reports Higher Q3 Profit Above View; To Buy Back Up To $500 Mln Of Shares

Abercrombie & Fitch Co. (ANF) on Tuesday reported higher net income in the third quarter, helped by revenue growth in its largest market U.S and also improved digital sales. The Board also approved a new share buyback program of up to $500 million.

Net income was $47.23 million or $0.77 per share in the third quarter, higher than 42.27 million or $0.66 per share in the same quarter a year ago.

Excluding one-time items, earnings were $0.86 per share, that beat the average estimate of ten analysts polled by Thomson Reuters at $0.66 per share. Analysts' estimates typically exclude special items.

Net sales for the quarter increased 10 percent year-over-year at $905.16 million from $819.65 million. The consensus estimate was for $896.86 million.

There has been a 17% growth in its U.S. market year-on-year. It also reported digital sales growth of 8 percent from last year.

The company's Board has approved a new share repurchase program of up to $500 million, replacing the old one of 10 million shares, announced in February, which had about 3.9 million shares remaining.

Abercrombie & Fitch stock is down more than 6% in pre-market. Monday it closed at $47.04, up $1.85 or 4.09%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The TJX Companies, Inc. (TJX) said its first-quarter pretax profit margin and earnings per share, each on an adjusted basis, exceeded its plans even though sales were slightly below planned range. Adjusted pretax margin was 9.4%, excluding a 1.9 percentage point charge related to a write-down of the... Apple Inc. is delaying its latest plan to ask employees to come back to the office three days a week, but will continue with its plan of two days in office a week, Bloomberg reported. Citing an internal memo, the report also said the tech major is again requiring its staff to wear masks in common spaces, meeting rooms, hallways, and elevators, as well as at 100 US stores. The U.S. Food and Drug Administration or FDA has urged infant formula manufacturers to import infant formula products to the United States to meet the ongoing severe supply shortage. In order to further increase the availability of infant formula in the country, while protecting the health of infants, the regulator announced a guidance outlining increased flexibilities for the global manufacturers
Follow RTT